Catalina Capital Group LLC Has $325,000 Holdings in UnitedHealth Group Incorporated $UNH

Catalina Capital Group LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 40.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,042 shares of the healthcare conglomerate’s stock after selling 713 shares during the quarter. Catalina Capital Group LLC’s holdings in UnitedHealth Group were worth $325,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of UNH. Brighton Jones LLC boosted its stake in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Apella Capital LLC boosted its stake in shares of UnitedHealth Group by 44.1% during the first quarter. Apella Capital LLC now owns 1,682 shares of the healthcare conglomerate’s stock valued at $973,000 after purchasing an additional 515 shares in the last quarter. Nixon Peabody Trust Co. boosted its stake in shares of UnitedHealth Group by 34.0% during the first quarter. Nixon Peabody Trust Co. now owns 536 shares of the healthcare conglomerate’s stock valued at $281,000 after purchasing an additional 136 shares in the last quarter. Finally, Johnson & White Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 1.5% during the first quarter. Johnson & White Wealth Management LLC now owns 1,798 shares of the healthcare conglomerate’s stock valued at $942,000 after purchasing an additional 26 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Barclays lifted their price target on UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Piper Sandler cut their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. KeyCorp cut their price objective on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Finally, JPMorgan Chase & Co. cut their price objective on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 6th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Price Performance

Shares of UNH opened at $353.26 on Friday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The business’s 50 day moving average price is $306.25 and its two-hundred day moving average price is $356.57. The firm has a market cap of $319.94 billion, a PE ratio of 15.31, a price-to-earnings-growth ratio of 2.27 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.